FindTrial
Sign In

To study the role of "anti H pylori drugs" in treating patients who are H pylori positive and suffering with non-ulcer dyspepsia.

"Analysing the effectiveness of anti H pylori therapy in patients with non-ulcer dyspepsia diagnosed by Rome IV criteria and having H pylori positive status"

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/02/031445
Enrollment
73
Registered
2021-02-22
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K30- Functional dyspepsia

Interventions

None listed

Sponsors

Dr VIVEK BHAVANAM
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Rome IV Criteria One or more of the following: 1. Bothersome postprandial fullness 2. Bothersome early satiation 3. Bothersome epigastric pain 4. Bothersome epigastric burning AND No evidence of structural disease(including at upper GI endoscopy) that is likely to explain the symptoms. Criteria fulfilled for the last 3 months with symptom onset at least 6 months before diagnosis.

Exclusion criteria

Exclusion criteria: 1. Any evidence of organic (pancreatobiliary disease, oesophagitis, peptic ulcer disease and neoplastic disease), drug-induced (non steroidal anti-inflammatory drugs), endocrine and metabolic disorders diagnosed by appropriate investigations. 2. Symptoms that are relieved by evacuation of feces or gas 3. Persistent vomiting 4. Biliary pain 5. Any erosion/ulcer in upper GI endoscopy 6. Pregnant women

Design outcomes

Primary

MeasureTime frame
Dyspeptic symptoms assessment with the help of standard dyspeptic scores before and after completion of anti H pylori therapyTimepoint: 1 month(for completion of anti H pylori therapy)—

Secondary

MeasureTime frame
The status of the patients for H pylori (positive or negative) after receiving anti H pylori therapy.Timepoint: 15 days after completion of the treatment course (to obtain the HPE report)—

Countries

India

Contacts

Public ContactDr SHARUN ABEY KURIAN

Kasturba Medical College and Hospital, Manipal.

dinesh.bv@manipal.edu9448654410

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026